Alkaline phosphatase: A possible treatment for sepsis-associated acute kidney injury in critically Ill patients

American Journal of Kidney Diseases

Volumn 63, Issue 6, 2014, Pages 1038-1048

  Peters, Esther ^a,b   Heemskerk, Suzanne ^a,b   Masereeuw, Rosalinde ^b   Pickkers, Peter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute kidney injury; adenosine; alkaline phosphatase; biopharmaceutical; hypoxia; renal failure; renal inflammation; sepsis; systemic inflammation

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; ALKALINE PHOSPHATASE; CREATININE; DIPYRIDAMOLE; ENDOTOXIN; HYPERTENSIVE FACTOR; LIPOPOLYSACCHARIDE;

ABDOMINAL AORTA ANEURYSM; ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; AGED; ANTIBIOTIC THERAPY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOENERGY; CASE REPORT; CELL PROTECTION; CELL STRESS; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; DEPHOSPHORYLATION; DETOXIFICATION; GRAM NEGATIVE AEROBIC RODS AND COCCI; HUMAN; HYPOXIA; INFLAMMATION; INTESTINE ISCHEMIA; KIDNEY DISEASE; KIDNEY FUNCTION; LAPAROTOMY; MALE; MEDIATOR; MICROCIRCULATION; NEPHRITIS; PHASE 2 CLINICAL TRIAL (TOPIC); RENAL PROTECTION; SEPSIS; THERAPY EFFECT; WOUND DEHISCENCE;

ACUTE KIDNEY INJURY; ADENOSINE; ALKALINE PHOSPHATASE; BIOPHARMACEUTICAL; HYPOXIA; RENAL FAILURE; RENAL INFLAMMATION; SEPSIS; SYSTEMIC INFLAMMATION;

ACUTE KIDNEY INJURY; AGED; ALKALINE PHOSPHATASE; ANOXIA; CRITICAL ILLNESS; HUMANS; KIDNEY; MALE; MICROCIRCULATION; PHOSPHORYLATION; SEPSIS;

EID: 84901498139     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.11.027     Document Type: Article

References (100)

1. J. Case, S. Khan, R. Khalid, and A. Khan Epidemiology of acute kidney injury in the intensive care unit Crit Care Res Pract 2013 2013 479730
2. R. Goldberg, and P. Dennen Long-term outcomes of acute kidney injury Adv Chronic Kidney Dis 15 3 2008 297 307
3. S.M. Bagshaw, C. George, R. Bellomo ANZICS Database Management Committee Early acute kidney injury and sepsis: a multicentre evaluation Crit Care 12 2 2008 R47
4. S. Heemskerk, R. Masereeuw, and O. Moesker et al. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients Crit Care Med 37 2 2009 417 423 e411
5. P. Pickkers, S. Heemskerk, and J. Schouten et al. Alkaline phosphatase for treatment of sepsis-induced acute kidney injury: a prospective randomized double-blind placebo-controlled trial Crit Care 16 1 2012 R14
6. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1 1976 31 41
7. J. Prowle, S.M. Bagshaw, and R. Bellomo Renal blood flow, fractional excretion of sodium and acute kidney injury: time for a new paradigm? Curr Opin Crit Care 18 6 2012 585 592
8. A. Romanovsky, C. Morgan, and S.M. Bagshaw Pathophysiology and management of septic acute kidney injury Pediatr Nephrol 29 1 2014 1 12
9. T. Gustot Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response Curr Opin Crit Care 17 2 2011 153 159
10. H.K. Eltzschig, M.V. Sitkovsky, and S.C. Robson Purinergic signaling during inflammation N Engl J Med 367 24 2012 2322 2333
11. H.K. Eltzschig, and T. Eckle Ischemia and reperfusion - from mechanism to translation Nat Med 17 11 2011 1391 1401
12. T. Kawai, and S. Akira TLR signaling Semin Immunol 19 1 2007 24 32
13. J.L. Vincent, J. Rello, and J. Marshall et al. International study of the prevalence and outcomes of infection in intensive care units JAMA 302 21 2009 2323 2329
14. J. Cohen The immunopathogenesis of sepsis Nature 420 6917 2002 885 891
15. A. Barratt-Due, S.E. Pischke, and O.L. Brekke et al. Bride and groom in systemic inflammation - the bells ring for complement and Toll in cooperation Immunobiology 217 11 2012 1047 1056
16. J.M. Cavaillon, M. Adib-Conquy, C. Fitting, C. Adrie, and D. Payen Cytokine cascade in sepsis Scand J Infect Dis 35 9 2003 535 544
17. T.M. El-Achkar, X. Huang, Z. Plotkin, R.M. Sandoval, G.J. Rhodes, and P.C. Dagher Sepsis induces changes in the expression and distribution of Toll-like receptor 4 in the rat kidney Am J Physiol Renal Physiol 290 5 2006 F1034 F1043
18. D.W. Good, T. George, and B.A. Watts III Lipopolysaccharide directly alters renal tubule transport through distinct TLR4-dependent pathways in basolateral and apical membranes Am J Physiol Renal Physiol 297 4 2009 F866 F874
19. R. Kalakeche, T. Hato, and G. Rhodes et al. Endotoxin uptake by S1 proximal tubular segment causes oxidative stress in the downstream S2 segment J Am Soc Nephrol 22 8 2011 1505 1516
20. A. Akcay, Q. Nguyen, and C.L. Edelstein Mediators of inflammation in acute kidney injury Mediators Inflamm 2009 2009 137072
21. A. Castoldi, T.T. Braga, and M. Correa-Costa et al. TLR2, TLR4 and the MYD88 signaling pathway are crucial for neutrophil migration in acute kidney injury induced by sepsis PloS One 7 5 2012 e37584
22. A. Zarjou, and A. Agarwal Sepsis and acute kidney injury J Am Soc Nephrol 22 6 2011 999 1006
23. A. Bajwa, G.R. Kinsey, and M.D. Okusa Immune mechanisms and novel pharmacological therapies of acute kidney injury Curr Drug Targets 10 12 2009 1196 1204
24. S. Heemskerk, A. van Koppen, and L. van den Broek et al. Nitric oxide differentially regulates renal ATP-binding cassette transporters during endotoxemia Pflugers Arch 454 2 2007 321 334
25. S.K. Jo, D.R. Cha, and W.Y. Cho et al. Inflammatory cytokines and lipopolysaccharide induce Fas-mediated apoptosis in renal tubular cells Nephron 91 3 2002 406 415
26. U.K. Messmer, V.A. Briner, and J. Pfeilschifter Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells Kidney Int 55 6 1999 2322 2337
27. N. Lerolle, D. Nochy, and E. Guerot et al. Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration Intensive Care Med 36 3 2010 471 478
28. R.G. Evans, C. Ince, and J.A. Joles et al. Haemodynamic influences on kidney oxygenation: clinical implications of integrative physiology Clin Exp Pharmacol Physiol 40 2 2013 106 122
29. C. Ince The microcirculation is the motor of sepsis Crit Care 9 suppl 4 2005 S13 S19
30. Z. Wang, C. Herzog, G.P. Kaushal, N. Gokden, and P.R. Mayeux Actinonin, a meprin A inhibitor, protects the renal microcirculation during sepsis Shock 35 2 2011 141 147
31. L. Wu, M.M. Tiwari, and K.J. Messer et al. Peritubular capillary dysfunction and renal tubular epithelial cell stress following lipopolysaccharide administration in mice Am J Physiol Renal Physiol 292 1 2007 F261 F268
32. M. Le Dorze, M. Legrand, D. Payen, and C. Ince The role of the microcirculation in acute kidney injury Curr Opin Crit Care 15 6 2009 503 508
33. S.N. Heyman, R.G. Evans, S. Rosen, and C. Rosenberger Cellular adaptive changes in AKI: mitigating renal hypoxic injury Nephrol Dial Transplant 27 5 2012 1721 1728
34. M. Sitkovsky, and D. Lukashev Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors Nat Rev Immunol 5 9 2005 712 721
35. H.K. Eltzschig Adenosine: an old drug newly discovered Anesthesiology 111 4 2009 904 915
36. S.C. Yap, and H.T. Lee Adenosine and protection from acute kidney injury Curr Opin Nephrol Hypertens 21 1 2012 24 32
37. B.P. Ramakers, N.P. Riksen, J.G. van der Hoeven, P. Smits, and P. Pickkers Modulation of innate immunity by adenosine receptor stimulation Shock 36 3 2011 208 215
38. V. Vallon, B. Muhlbauer, and H. Osswald Adenosine and kidney function Physiol Rev 86 3 2006 901 940
39. F. Di Sole Adenosine and renal tubular function Curr Opin Nephrol Hypertens 17 4 2008 399 407
40. D.G. Shirley, R.M. Vekaria, and J. Sevigny Ectonucleotidases in the kidney Purinergic Signal 5 4 2009 501 511
41. M.V. Sitkovsky, D. Lukashev, and S. Apasov et al. Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors Annu Rev Immunol 22 2004 657 682
42. L. Gunaratnam, and J.V. Bonventre HIF in kidney disease and development J Am Soc Nephrol 20 9 2009 1877 1887
43. V.H. Haase Hypoxia-inducible factors in the kidney Am J Physiol Renal Physiol 291 2 2006 F271 F281
44. V. Roberts, B. Lu, S. Rajakumar, P.J. Cowan, and K.M. Dwyer The CD39-adenosinergic axis in the pathogenesis of renal ischemia-reperfusion injury Purinergic Signal 9 2 2013 135 143
45. N. Arulkumaran, C.M. Turner, M.L. Sixma, M. Singer, R. Unwin, and F.W. Tam Purinergic signaling in inflammatory renal disease Front Physiol 4 2013 194
46. B. McDonald, K. Pittman, and G.B. Menezes et al. Intravascular danger signals guide neutrophils to sites of sterile inflammation Science 330 6002 2010 362 366
47. S.S. Iyer, W.P. Pulskens, and J.J. Sadler et al. Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome Proc Natl Acad Sci U S A 106 48 2009 20388 20393
48. A. Nishiyama, A. Miyatake, and Y. Aki et al. Adenosine A(1) receptor antagonist KW-3902 prevents hypoxia-induced renal vasoconstriction J Pharmacol Exp Ther 291 3 1999 988 993
49. H.T. Lee, and C.W. Emala Adenosine attenuates oxidant injury in human proximal tubular cells via A(1) and A(2a) adenosine receptors Am J Physiol Renal Physiol 282 5 2002 F844 F852
50. A. Harrois, O. Huet, and J. Duranteau Alterations of mitochondrial function in sepsis and critical illness Curr Opin Anaesthesiol 22 2 2009 143 149
51. F. Porta, J. Takala, and C. Weikert et al. Effects of prolonged endotoxemia on liver, skeletal muscle and kidney mitochondrial function Crit Care 10 4 2006 R118
52. C.N. May, K. Ishikawa, and L. Wan et al. Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion Intensive Care Med 38 5 2012 886 893
53. R. Frithiof Sepsis-induced acute kidney injury-is there a lack of energy? Intensive Care Med 38 5 2012 735 737
54. M. Joannidis, W. Druml, and L.G. Forni et al. Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM Intensive Care Med 36 3 2010 392 411
55. R. Bellomo, M. Chapman, S. Finfer, K. Hickling, and J. Myburgh Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group Lancet 356 9248 2000 2139 2143
56. K. Janssen van Doorn, H. Spapen, C. Geers, M. Diltoer, and W. Shabana Sepsis-related acute kidney injury: a protective effect of drotrecogin alpha (activated) treatment? Acta Anaesthesiol Scand 52 9 2008 1259 1264
57. P. Zhang, Y. Yang, R. Lv, Y. Zhang, W. Xie, and J. Chen Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial Nephrol Dial Transplant 27 3 2012 967 973
58. S.K. Jo, M.H. Rosner, and M.D. Okusa Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon Clin J Am Soc Nephrol 2 2 2007 356 365
59. H. Bentala, W.R. Verweij, A. Huizinga-Van der Vlag, A.M. van Loenen-Weemaes, D.K. Meijer, and K. Poelstra Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide Shock 18 6 2002 561 566
60. J.E. Coleman Structure and mechanism of alkaline phosphatase Annu Rev Biophys Biomol Struct 21 1992 441 483
61. M. Krishnaswamy, and U.W. Kenkare The effect of pH, temperature, and organic solvents on the kinetic parameters of Escherichia coli alkaline phosphatase J Biol Chem 245 15 1970 3956 3963
62. J.L. Millan Alkaline phosphatases. Structure, substrate specificity and functional relatedness to other members of a large superfamily of enzymes Purinergic Signal 2 2 2006 335 341
63. D.W. Moss Alkaline phosphatase isoenzymes Clin Chem 28 10 1982 2007 2016
64. J.P. Lalles Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet Nutr Rev 68 6 2010 323 332
65. A. Neumann, T. Keller, D. Jocham, and C. Doehn [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer] Aktuelle Urol 42 5 2011 311 315
66. P.D. Ross, B.C. Kress, R.E. Parson, R.D. Wasnich, K.A. Armour, and I.A. Mizrahi Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study Osteoporos Int 11 1 2000 76 82
67. A. Siddique, and K.V. Kowdley Approach to a patient with elevated serum alkaline phosphatase Clin Liver Dis 16 2 2012 199 229
68. G.F. Verpooten, E.J. Nouwen, M.F. Hoylaerts, P.G. Hendrix, and M.E. de Broe Segment-specific localization of intestinal-type alkaline phosphatase in human kidney Kidney Int 36 4 1989 617 625
69. E.J. Nouwen, and M.E. De Broe Human intestinal versus tissue-nonspecific alkaline phosphatase as complementary urinary markers for the proximal tubule Kidney Int Suppl 47 1994 S43 S51
70. U. Domar, B. Nilsson, V. Baranov, U. Gerdes, and T. Stigbrand Expression of intestinal alkaline phosphatase in human organs Histochemistry 98 6 1992 359 364
71. S.J. Khundmiri, M. Asghar, F. Khan, S. Salim, and A.N. Yusufi Effect of reversible and irreversible ischemia on marker enzymes of BBM from renal cortical PT subpopulations Am J Physiol 273 6, pt 2 1997 F849 F856
72. G. Coux, L. Trumper, and M.M. Elias Renal function and cortical (Na(+)+K(+))-ATPase activity, abundance and distribution after ischaemia-reperfusion in rats Biochim Biophys Acta 1586 1 2002 71 80
73. D. Gluck, H. Wiedeck, and M. van Wickern et al. Anti-lipopolysaccharide- immunoglobulin (IgG-anti-LPS) therapy in intensive care patients following surgery from infectious disease Infusionstherapie 17 4 1990 220 223
74. S.M. Opal, P.F. Laterre, and B. Francois et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial JAMA 309 11 2013 1154 1162
75. K. Poelstra, W.W. Bakker, P.A. Klok, J.A. Kamps, M.J. Hardonk, and D.K. Meijer Dephosphorylation of endotoxin by alkaline phosphatase in vivo Am J Pathol 151 4 1997 1163 1169
76. C. Beumer, M. Wulferink, W. Raaben, D. Fiechter, R. Brands, and W. Seinen Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets J Pharmacol Exp Ther 307 2 2003 737 744
77. W.R. Verweij, H. Bentala, and A. Huizinga-van der Vlag et al. Protection against an Escherichia coli-induced sepsis by alkaline phosphatase in mice Shock 22 2 2004 174 179
78. S.Q. van Veen, A.K. van Vliet, M. Wulferink, R. Brands, M.A. Boermeester, and T.M. van Gulik Bovine intestinal alkaline phosphatase attenuates the inflammatory response in secondary peritonitis in mice Infect Immun 73 7 2005 4309 4314
79. F. Su, R. Brands, and Z. Wang et al. Beneficial effects of alkaline phosphatase in septic shock Crit Care Med 34 8 2006 2182 2187
80. I. Koyama, T. Matsunaga, T. Harada, S. Hokari, and T. Komoda Alkaline phosphatases reduce toxicity of lipopolysaccharides in vivo and in vitro through dephosphorylation Clin Biochem 35 6 2002 455 461
81. E.L. Campbell, C.F. MacManus, and D.J. Kominsky et al. Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification Proc Natl Acad Sci U S A 107 32 2010 14298 14303
82. J.H. Holthoff, Z. Wang, K.A. Seely, N. Gokden, and P.R. Mayeux Resveratrol improves renal microcirculation, protects the tubular epithelium, and prolongs survival in a mouse model of sepsis-induced acute kidney injury Kidney Int 81 4 2012 370 378
83. M.J. Parmely, W.W. Zhou, C.K. Edwards III, D.R. Borcherding, R. Silverstein, and D.C. Morrison Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge J Immunol 151 1 1993 389 396
84. G.W. Sullivan, G. Fang, J. Linden, and W.M. Scheld A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis J Infect Dis 189 10 2004 1897 1904
85. B.P. Ramakers, N.P. Riksen, and T.H. Stal et al. Dipyridamole augments the antiinflammatory response during human endotoxemia Crit Care 15 6 2011 R289
86. G. Gallos, T.D. Ruyle, C.W. Emala, and H.T. Lee A1 adenosine receptor knockout mice exhibit increased mortality, renal dysfunction, and hepatic injury in murine septic peritonitis Am J Physiol Renal Physiol 289 2 2005 F369 F376
87. H.T. Lee, M. Kim, J.D. Joo, G. Gallos, J.F. Chen, and C.W. Emala A3 adenosine receptor activation decreases mortality and renal and hepatic injury in murine septic peritonitis Am J Physiol Regul Integr Comp Physiol 291 4 2006 R959 R969
88. G. Hasko, B. Csoka, and B. Koscso et al. Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis J Immunol 187 8 2011 4256 4267
89. P. Pickkers, F. Snellen, and P. Rogiers et al. Clinical pharmacology of exogenously administered alkaline phosphatase Eur J Clin Pharmacol 65 4 2009 393 402
90. K.L. de Abreu, G.B. Silva Junior, and A.G. Barreto et al. Acute kidney injury after trauma: prevalence, clinical characteristics and RIFLE classification Indian J Crit Care Med 14 3 2010 121 128
91. M.H. Rosner, and M.D. Okusa Acute kidney injury associated with cardiac surgery Clin J Am Soc Nephrol 1 1 2006 19 32
92. AM-Pharma. Human recombinant alkaline phosphatase development. http://www.am-pharma.com/products. Accessed August 7, 2013.
93. AM-Pharma. Phase I trial with new recombinant human alkaline phosphatase. http://www.am-pharma.com/blog/2013/09/am-pharma-returns-to-clinic-with-phase-i- trial-of-new-recombinant-human-alkaline-phosphatase. Accessed October 15, 2013.
94. AM-Pharma. Results of phase II clinical trial with alkaline phosphatase in acute kidney injury. http://www.am-pharma.com/files/download/7. Accessed August 7, 2013.
95. H. Eutamene, V. Theodorou, and F. Schmidlin et al. LPS-induced lung inflammation is linked to increased epithelial permeability: role of MLCK Eur Respir J 25 5 2005 789 796
96. R. Huizinga, K.L. Kreft, and S. Onderwater et al. Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation J Neuroinflammation 9 2012 266
97. K.M. Riggle, R.M. Rentea, S.R. Welak, K.A. Pritchard Jr., K.T. Oldham, and D.M. Gourlay Intestinal alkaline phosphatase prevents the systemic inflammatory response associated with necrotizing enterocolitis J Surg Res 180 1 2013 21 26
98. R.M. Rentea, J.L. Liedel, and K. Fredrich et al. Enteral intestinal alkaline phosphatase administration in newborns decreases iNOS expression in a neonatal necrotizing enterocolitis rat model J Pediatr Surg 48 1 2013 124 128
99. R.M. Rentea, J.L. Liedel, and S.R. Welak et al. Intestinal alkaline phosphatase administration in newborns is protective of gut barrier function in a neonatal necrotizing enterocolitis rat model J Pediatr Surg 47 6 2012 1135 1142
100. M. Lukas, P. Drastich, and M. Konecny et al. Exogenous alkaline phosphatase for the treatment of patients with moderate to severe ulcerative colitis Inflamm Bowel Dis 16 7 2010 1180 1186